Boston Scientific Corp (BSX)vsNortech Systems Incorporated (NSYS)
BSX
Boston Scientific Corp
$48.55
-0.32%
HEALTHCARE · Cap: $70.87B
NSYS
Nortech Systems Incorporated
$16.68
+0.79%
HEALTHCARE · Cap: $47.42M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 16826% more annual revenue ($20.61B vs $121.79M). BSX leads profitability with a 17.3% profit margin vs 0.8%. BSX trades at a lower P/E of 19.9x. BSX earns a higher WallStSmart Score of 76/100 (B+).
BSX
Strong Buy76
out of 100
Grade: B+
NSYS
Hold46
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-29.4%
Fair Value
$37.35
Current Price
$48.55
$11.20 premium
Intrinsic value data unavailable for NSYS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 20.6%
Reasonable price relative to book value
Earnings expanding 125.7% YoY
Safe zone — low bankruptcy risk
Areas to Watch
No major concerns identified
Smaller company, higher risk/reward
ROE of 3.0% — below average capital efficiency
0.8% margin — thin
Operating margin of 0.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : NSYS
The strongest argument for NSYS centers on Price/Book, EPS Growth, Altman Z-Score. Revenue growth of 12.7% demonstrates continued momentum.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : NSYS
The primary concerns for NSYS are Market Cap, Return on Equity, Profit Margin. A P/E of 44.7x leaves little room for execution misses. Thin 0.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
BSX profiles as a mature stock while NSYS is a value play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.62 — expect wider price swings.
NSYS is growing revenue faster at 12.7% — sustainability is the question.
BSX generates stronger free cash flow (171M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (76/100 vs 46/100), backed by strong 17.3% margins and 11.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Nortech Systems Incorporated
HEALTHCARE · MEDICAL DEVICES · USA
Nortech Systems Incorporated is an electronic manufacturing services company in the United States, Mexico, and China. The company is headquartered in Maple Grove, Minnesota.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?